Nocipoint Therapy Versus Standard Physical Therapy Using Electrical Stimulation for Chronic Pain

The purpose of this study is to validate the efficacy of Nocipoint therapy on chronic pain,
and compare it with standard physical therapy using electrical stimulation on patients with
chronic pain.

Invented by Dr. Charlie Koo at Stanford University, Nocipoint Therapy is a specific
procedure with precise location, duration and intensity of TENS stimulation within the
general FDA guidelines. The therapy substantially relieves general muscular/tendon pain and
persistently restores the muscle and tendon function. The surface locations of nociceptors
at the free nerve ending (i.e., "Nocipoints") are focused on in the stimulation therapy.
Multiple clinical uses of Nocipoint Therapy confirmed the consistent efficacy of such
stimulation at Nocipoints. An observational study of Nocipoint therapy within the
FDA-approved use of TENS demonstrated an encouraging 93% success rate in eliminating the
chronic pain, such as frozen shoulder pain, within 2-3 sessions. It is an
order-of-magnitude improvement over the non-specific application of TENS and any other
modalities in pain treatment. A unique neuro-immuno-signaling pathway that implicates the
activation of adult stem cells, such as satellite cells in muscles, is implicated based on
such a high success rate.